- Home
- MEDP vs ULS Comparison
MEDP vs ULS Comparison
Compare MEDP & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- ULS
- Stock Information
- Founded
- MEDP 1992
- ULS 1894
- Country
- MEDP United States
- ULS United States
- Employees
- MEDP N/A
- ULS N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- ULS
- Sector
- MEDP Health Care
- ULS
- Exchange
- MEDP Nasdaq
- ULS Nasdaq
- Market Cap
- MEDP 13.4B
- ULS 15.8B
- IPO Year
- MEDP 2016
- ULS 2024
- Fundamental
- Price
- MEDP $593.52
- ULS $86.87
- Analyst Decision
- MEDP Hold
- ULS Hold
- Analyst Count
- MEDP 12
- ULS 8
- Target Price
- MEDP $465.18
- ULS $78.75
- AVG Volume (30 Days)
- MEDP 330.7K
- ULS 589.4K
- Earning Date
- MEDP 10-22-2025
- ULS 11-04-2025
- Dividend Yield
- MEDP N/A
- ULS 0.60%
- EPS Growth
- MEDP 25.36
- ULS 10.58
- EPS
- MEDP 14.32
- ULS 1.67
- Revenue
- MEDP $2,358,373,000.00
- ULS $3,003,000,000.00
- Revenue This Year
- MEDP $21.48
- ULS $6.79
- Revenue Next Year
- MEDP $11.90
- ULS $6.23
- P/E Ratio
- MEDP $41.21
- ULS $51.87
- Revenue Growth
- MEDP 13.88
- ULS 6.68
- 52 Week Low
- MEDP $250.05
- ULS $48.54
- 52 Week High
- MEDP $625.00
- ULS $91.95
- Technical
- Relative Strength Index (RSI)
- MEDP 61.33
- ULS 67.00
- Support Level
- MEDP $573.07
- ULS $84.17
- Resistance Level
- MEDP $609.13
- ULS $88.42
- Average True Range (ATR)
- MEDP 17.50
- ULS 2.63
- MACD
- MEDP -2.71
- ULS 0.09
- Stochastic Oscillator
- MEDP 55.78
- ULS 65.29
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.